Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-23-014873

EVP & Chief Medical Officer acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Rangwala Reshma EVP & Chief Medical Officer 2023-02-28 Grant or award +100,000 165,000 D: show line 1 in the form
Loading xslF345X03/doc4.xml…